Peapod Bio sponsoring SLAS Chicago Meet-Up
Join the Society of Laboratory Automation and Screening (SLAS) and the Chicago life sciences community at this regional meet-up, featuring a panel discussion “Assay to Asset: How Automation, AI, and New Business Models are Reshaping Early Drug Discovery.”
Learn from our expert panel, including Shana Kelley, Professor of Chemistry and Biomedical Engineering, Northwestern University and President, Chan Zuckerburg Biohub Chicago; John Flavin, Founder and CEO, Portal Innovations, and Robert Campbell, Chief Scientific Officer, Grove Biopharma and Editor-in-Chief, SLAS Discovery! Moderating this discussion is Peapod Bio Founder and CEO Zachary Gurard-Levin.
The event is FREE and is open to everyone! It’s a wonderful way to connect with others in the Chicago ecosystem.
EVENT DETAILS:
June 18, 2026
Portal Innovations
400 Aberdeen St. Suite 900
Chicago, IL
SLAS 2026
Visit Peapod Bio at the 2026 SLAS International Conference & Exhibition!
February 7-11, 2026 | Boston, MA
Booth #1129
Mark your calendars to join our Solution Spotlight presentation, poster presentation, and panels.
Solutions Spotlight:
Now you see it! High-throughput screening using MALDI MS and polymeric enrichment arrays (PEAs) to visualize the invisible
Monday, February 9 | 12:30 PM – 12:50 PM EST
Poster Presentation:
Assay development and high-throughput screen for Sortase A inhibitors using an innovative mass spectrometry platform to combat antibiotic resistant bacteria
Tuesday, February 10 | 2:00 PM – 3:00 PM EST | Poster #: 1073-D
Track: Assay Development and Screening
Panel Discussion:
The Innovation Nexus: Bridging Discovery, Imaging, and the Future
Tuesday, February 10 | 1:00 PM – 1:45 PM EST | NexusXP Pavillion
Short Course:
Get the word out! Strategic communication and marketing in the life sciences.
Saturday, February 7 | 8:30 AM – 12:00 PM EST
Peapod Bio CEO Zachary Gurard-Levin to present a Webinar November 18, 2025 hosted by Bruker.
Title: The evolution of combining surface chemistry and MALDI mass spectrometry: A powerful foundation for high-throughput screening
When: November 18, 2025 at 11:00 am EDT | 8:00 am PDT | 5:00 pm CEST followed by live Q&A.
In this webinar hosted by Bruker, Gurard-Levin will discuss the development of different surface chemistries and their applications in early drug discovery. He will showcase how innovation at the interface of surface chemistry, MALDI mass spectrometry, and biological assays are enabling new solutions for value-driven high-throughput screening platforms to accelerate drug discovery for even the most challenging targets. Finally, the webinar will highlight how Peapod Bio combines state-of-the-art MALDI instrumentation from Bruker with polymeric enrichment arrays (PEAs) to measure biochemical activities and binding interactions (in an affinity selection mass spectrometry (ASMS) platform) for virtually any target.
Key learning objectives:
- Understand how surface chemistry enhances assay design for small molecule drug discovery
- Explore the advantages of integrating surface chemistries with MALDI mass spectrometry for high-throughput screening
- Recognize the impact on small molecule drug discovery pipelines
Who should attend?
- Researchers interested in new workflows for high-throughput screening
- Scientists interested in high-throughput mass spectrometry
- Investigators working in biochemical and biophysical assay development
Register here to save your spot!
Meet Peapod Bio CEO in Boston September 23-24 at Discovery on Target 2025!
Peapod Bio Chief Executive Officer and Founder Zachary Gurard-Levin, PhD is attending the Discovery on Target Conference in Boston September 23-24. Click below to schedule a meeting to learn more about Peapod Bio’s innovative assay solutions to accelerate your drug discovery research.